Brief: New Data Demonstrate Protective Effects Of Altamira's Bentrio Under Controlled Grass Pollen Exposure

Altamira Therapeutics

08/11/2022 15:33

Nov 8 (Reuters) - Altamira Therapeutics Ltd  CYTO.O :
    * DATA PUBLISHED IN PEER-REVIEWED JOURNAL DEMONSTRATE
PROTECTIVE
EFFECTS OF ALTAMIRA'S BENTRIO UNDER CONTROLLED GRASS POLLEN
EXPOSURE
    * ALTAMIRA THERAPEUTICS - MEAN INCREASE OF TOTAL NASAL
SYMPTOM
SCORE 1.1 POINTS LOWER VERSUS. NO PROTECTION, PROVIDING
CLINICALLY MEANINGFUL IMPROVEMENT
    * ALTAMIRA THERAPEUTICS LTD - MEAN INCREASE OF TNSS 0.4
POINTS
LOWER VERSUS. ESTABLISHED POWDER ALLERGY BLOCKER SPRAY
    * ALTAMIRA THERAPEUTICS LTD - TREATMENT SAFE AND WELL
TOLERATED
    * ALTAMIRA THERAPEUTICS LTD - BENTRIO EFFICACY RATED 2X MORE
FAVORABLY BY PATIENTS

Source text for Eikon:  ID:nGNX48hDPk 
Further company coverage:  CYTO.O 
 ((reuters.briefs@thomsonreuters.com;))